Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01776242 · ClinicalTrials.gov registry record
Back Pain Outcomes Using Longitudinal Data (BOLD)
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 5,239
- Enrollment target
NCT01776242: Completed study, sponsored by University of Washington.
NCT01776242 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 5,239 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01776242 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 5,239 participants
- Enrollment target
Study Summary
The overall objective of BOLD is to establish a large, community-based registry (at least 5000 subjects) of patients aged 65 years and older presenting with new episodes of healthcare visits for back pain. BOLD's primary aim is to create an infrastructure that allows for the conduct of prospective, controlled studies comparing the effectiveness of diagnostic and treatment strategies for back pain in older adults.
Primary Outcome
24-item back pain specific, functional status questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,239 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-09 |
What the finished NCT01776242 record still lists
NCT01776242 is an observational study that tracks outcomes without assigning an intervention. Its 5,239 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01776242 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01776242 about?
NCT01776242 is a clinical study titled "Back Pain Outcomes Using Longitudinal Data (BOLD)". The overall objective of BOLD is to establish a large, community-based registry (at least 5000 subjects) of patients aged 65 years and older presenting with new episodes of healthcare visits for back pain. BOLD's primary aim is to create an infrastructure that allows for the conduct of prospective, ...
What is the current status of trial NCT01776242?
This trial is currently completed. The enrollment target is 5,239 participants. The study started on 2010-09. Estimated completion is 2013-09.
Who is sponsoring clinical trial NCT01776242?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06506344 · 5,250 participants · NA
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
- NCT05989308 · 5,200 participants · NA
MyChart Proxy Outreach to Parents (MyPOP)
- NCT06008197 · 5,200 participants · Phase 3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- NCT05135403 · 5,179 participants
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia